July 25, 2001
Monsanto net income up 5 percent
to $421 million for second quarter 2001; earnings per
share up 3 percent to $1.60
Sales of $2 billion flat for the second quarter; first-half
sales flat at $3.3 billion.
Increase of 4 percent sets quarterly record for global sales of
Roundup herbicide; U.S. branded
sales up 5 percent in key use season.
Other Developments
U.S. acreage for Monsanto's biotechnology-enhanced traits in
2001 estimated to rise by 11
percent to 80 million acres, with Roundup Ready soybeans and
cotton traits particularly strong.
Roundup Ready cotton approved for planting in Argentina.
Financial Summary
($ in millions, except per share) |
Second
Quarter
2001 |
Second
Quarter
2000 |
% chg |
Six Months
2001 |
Six Months
2000 |
% chg |
Net Sales |
$2,011 |
$2,007 |
-- |
$3,317 |
$3,328 |
-- |
EBIT
(excluding special items) |
$697 |
$672 |
4% |
$826 |
$799 |
3% |
EBITDA
(excluding special items) |
$829 |
$804 |
3% |
$1,095 |
$1,074 |
2% |
Reported Net Income
|
$389 |
$248 |
57% |
$444 |
$265 |
68% |
Reported Diluted EPS* |
$1.47 |
$0.96 |
53% |
$1.68 |
$1.03 |
63% |
Net Income
(excluding nonrecurring items)** |
$421 |
$402 |
5% |
$489 |
$469 |
4% |
Net Income Diluted EPS
(excluding nonrecurring items)** |
$1.60 |
$1.56 |
3% |
$1.86 |
$1.82 |
2% |
* EPS for second-quarter 2000 and
first-half 2000 were calculated using pro forma shares
outstanding.
** Net income and net income diluted EPS are before nonrecurring
items (see note 7 for details).
Results for 2000 are on a pro forma basis, assuming Monsanto's
reduced debt level as applied to all of 2000. EPS for all 2000
periods was calculated using pro forma shares outstanding.
St. Louis, Missouri
July 25, 2001
Monsanto Company (NYSE:
MON) today reported sales and earnings for the second quarter of
2001.
"Our U.S. business results were key to the company's overall
earnings improvement for the second quarter," said Monsanto
President and Chief Executive Officer Hendrik A. Verfaillie.
"U.S. customers continued their strong demand for our family of
Roundup herbicides, and farmers also continued to plant more
seeds containing our biotechnology-enhanced traits that help
them reduce their costs and better protect the environment."
Sales
Second-quarter net sales were flat at $2 billion. Sales would
have been 2 percent higher, if the effect of foreign currency
exchange was excluded. Global sales of Roundup herbicide
increased 4 percent and set a quarterly record, led by gains in
the United States and Argentina during the second quarter of
2001. Sales for the seeds and genomics segment were down 20
percent compared with second-quarter 2000 results.
Higher-than-normal returns of conventional corn seed in Latin
America negatively affected sales by roughly $70 million.
Sales for the first six months of 2001 of $3.3 billion also were
flat compared with sales in the first half of 2000. Solid U.S.
sales of Roundup herbicide and increased revenue from biotech
traits were offset primarily by corn seed returns in Latin
America. Sales during the first six months of 2001 would have
improved by almost 2 percent compared with first-half 2000
sales, if the effect of foreign currency exchange was excluded .
Reported Earnings
Second-quarter 2001 net income improved to $389 million from
last year's second-quarter net income. Earnings per share (EPS)
for the quarter increased to $1.47 per share. For the first half
of 2001, the company reported net income of $444 million,
compared with 2000 first-half net income of $265 million. EPS
for the six-month period increased to $1.68 per share.
2001 Second-Quarter and First-Half Earnings vs. 2000 Pro Forma
Second-Quarter and Pro
Forma First-Half Earnings
As discussed in this section, net income excludes nonrecurring
items which represents net income before an extraordinary charge
in 2001 for the early retirement of debt, the cumulative effect
of an accounting change effective Jan. 1, 2000, and
restructuring and other special items. As previously stated, the
company expects to take $425 million to $475 million in total
pretax restructuring and other special items for the two-year
period ending Dec. 31, 2001, of which $330 million was recorded
during 2000 and the first half of 2001 .
Monsanto's pro forma net income and earnings per pro forma share
for 2000 also have been adjusted to reflect the effect of a
capital contribution from Pharmacia Corporation and proceeds
from the company's initial public offering (IPO). This
adjustment is reflected as of Jan. 1, 2000, for 2000 results.
Second-quarter net income increased 5 percent to $421 million,
from $402 million in the second quarter of 2000. In the second
quarter of 2001, the company recorded nonrecurring aftertax
charges of $32 million, primarily associated with our
restructuring action to exit product lines or businesses and to
focus our efforts on key crops. In the second quarter of last
year, Monsanto recorded nonrecurring aftertax charges of $126
million, primarily associated with our restructuring plan. EPS
for the second quarter of 2001 increased 3 percent to $1.60 per
share.
For the six-month period, net income increased 4 percent to $489
million in 2001, from $469 million in the same period last year.
The nonrecurring items in both six-month periods were primarily
associated with our restructuring plan to focus our efforts on
key crops. The company recorded nonrecurring aftertax charges of
$45 million in the first half of 2001, while nonrecurring
aftertax charges of $149 million were recorded in the first six
months of 2000. First-half 2001 EPS was up 2 percent to $1.86
per share. Improved cost management in the quarter and first
half of 2001 contributed to increased earnings.
Segments
Monsanto reports its results in two segments: Agricultural
Productivity and Seeds and Genomics.
Agricultural Productivity: In the Agricultural Productivity
segment, global sales were up 8 percent for the second quarter
and 4 percent for the first half of 2001, led by increases for
branded Roundup herbicide in the U.S. and Argentinean markets.
If special items are excluded, earnings before interest and
taxes (EBIT), improved in both periods, driven by increased
sales and lower expenses. EBIT rose by 7 percent to $662 million
for the second quarter of 2001. EBIT increased slightly to $814
million in the first six months of 2001 versus $812 million in
the first six months of 2000.
Seeds and Genomics: Sales for the Seeds and Genomics segment
decreased $109 million, or 20
percent, to $437 million for the second quarter of 2001. For the
first half of 2001, sales for this segment decreased 10 percent,
from $1 billion to $935 million, primarily because of seed
returns in Latin America. However, year-to-date sales of Roundup
Ready soybean traits and cotton traits were particularly strong.
EBIT, if special items are excluded, declined by 36 percent to
$35 million in the second quarter of 2001 for the Seeds and
Genomics segment. For the six-month period, EBIT improved by $25
million, from a loss of $13 million in the first half of 2000 to
earnings of $12 million in the same period this year. Better
cost management and increased revenues from biotechnology traits
drove the first-half EBIT improvement.
Other Developments
Monsanto estimates that its insect-resistant and Roundup Ready
technologies were used on
approximately 80 million acres in the United States during the
2001 growing season, an increase of 11 percent compared with 72
million acres in the previous year. Initial results indicate
that acres planted with Roundup Ready crops (soybeans, corn and
cotton) rose 17 percent compared with 2000 acres. Acreage
estimates for Monsanto's biotechnology traits in the United
States by crop follow.
|
2001
(in M of acres) |
2000
(in M of acres) |
%
change |
U.S. soybean
traits |
52.0 |
45.0 |
16% |
U.S. corn traits |
17.5 |
17.3 |
1% |
U.S. cotton
traits |
10.5 |
9.7 |
8% |
TOTAL |
80.0 |
72.0 |
11% |
In late April, Monsanto and its
seed partners were granted final approval to commercialize
Roundup Ready cotton in Argentina. The joint venture company CDM
Mandiyu S.R.L. plans a small commercial launch of Roundup Ready
cotton seed this fall. Argentinean farmers have widely adopted
other Monsanto traits for cotton, corn and soybeans during the
past several years. Roundup Ready cotton will offer cotton
growers there a more flexible weed control system with
significant environmental and economic benefits
Future Guidance
Because of the continuing effects of foreign currency exchange,
Monsanto's sales growth for 2001 is expected to be in the range
of 2 percent to 4 percent for the year. As previously stated,
2001 earnings, when compared with 2000 pro forma results that
exclude nonrecurring items, should increase between 9 percent
and 13 percent. Third-quarter 2001 EPS, excluding nonrecurring
items, is expected to be approximately the same with
third-quarter 2000 EPS, excluding nonrecurring items, which was
a loss of 13 cents per share.
The company also reiterated that it plans to improve its free
cash flow (cash provided by operations less cash required by
investing activities), and expects to have positive free cash
flow in 2001.
Monsanto Company, an 85 percent-owned subsidiary of Pharmacia
Corporation, is a leading global
provider of technology-based solutions and agricultural products
that improve farm productivity and food quality.
Roundup and Roundup Ready are
trademarks owned by Monsanto Technology LLC.
Company news release
N3671 is next
|